v3.26.1
Consolidated Balance Sheets - USD ($)
Jun. 30, 2026
Dec. 31, 2025
CURRENT ASSETS    
Cash $ 111 $ 815
Total current assets 111 815
OTHER ASSETS    
Right of first refusal agreement cost (less accumulated amortization of $25,000 and $25,000)
Total assets 111 815
CURRENT LIABILITIES    
Accounts payable 12,239 8,514
Accrued officers’ compensation 470,350
Total current liabilities and total liabilities 12,239 742,464
STOCKHOLDERS’ (DEFICIENCY)    
Common stock; 2,000,000,000 shares authorized, $.001 par value, as of June 30, 2026 and December 31, 2025, there are 994,379 and 944,935 shares outstanding, respectively 1,349,983 1,349,933
Additional paid-in capital 3,044,214 2,891,262
Accumulated deficit (4,413,955) (4,991,957)
Total stockholders’ (deficiency) (12,128) (741,649)
Total liabilities and stockholders’ (deficiency) 111 815
Series A Convertible Preferred Stock [Member]    
STOCKHOLDERS’ (DEFICIENCY)    
Preferred shares value 7,629 9,112
Series B Convertible Preferred Stock [Member]    
STOCKHOLDERS’ (DEFICIENCY)    
Preferred shares value 1 1
Related Party [Member]    
CURRENT LIABILITIES    
Loans payable to related parties $ 263,600